Cargando…
Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections
The fetal/neonatal period represents both a unique window of opportunity for interventions as well as vulnerability to a number of viral infections. While Herpesviruses such as herpes simplex virus (HSV) are highly prevalent and typically of little consequence among healthy adults, they are among th...
Autores principales: | Backes, Iara M., Leib, David A., Ackerman, Margaret E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398215/ https://www.ncbi.nlm.nih.gov/pubmed/36016956 http://dx.doi.org/10.3389/fimmu.2022.959603 |
Ejemplares similares
-
Antibody effector functions are required for broad and potent protection of neonates from herpes simplex virus infection
por: Slein, Matthew D., et al.
Publicado: (2023) -
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
por: Hu, Mingming, et al.
Publicado: (2023) -
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017) -
Herpes Simplex Virus and Pattern Recognition Receptors: An Arms Race
por: Zhao, Jun, et al.
Publicado: (2021) -
When herpes simplex virus encephalitis meets antiviral innate immunity
por: Zhang, Linhai, et al.
Publicado: (2023)